Int J Oral Implantol (Berl). 2024 Nov 19;17(4):345-356.
To compare the medium- and long-term efficacy of implants and removable prostheses used to manage edentulous patients with florid cemento-osseous dysplasia.
The PubMed, Web of Science and Google Scholar databases were searched from December 2022 to March 2023. Two independent reviewers completed the search using a population, intervention, comparison, outcome and time questionnaire. Articles were selected based on strict inclusion and exclusion criteria. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses workflow was employed to represent the number of included and excluded articles. The risk of bias was analysed using the Joanna Briggs Institute Critical Appraisal Checklist. From the included articles, the following information was extracted: demographics, concurrent medical conditions, characteristics of florid cemento-osseous dysplasia (clinical, radiographic and histological), interventions performed on the edentulous sites (placement of implants or removable prostheses), outcomes after the interventions (complications, success, bone loss, implant loss and relapse) and follow-up period.
Six articles were included in the final analysis, and implants and removable prostheses were the devices reported to have been used to restore the edentulous sites. Eleven implants were placed in patients with florid cemento-osseous dysplasia, with a survival rate of 91%. Three out of three removable prostheses were delivered and all resulted in symptoms and required surgical interventions.
Removable prostheses in patients with florid cemento-osseous dysplasia can present complications. Implant placement within the florid cemento-osseous dysplasia lesion is unpredictable and can result in radiolucency and implant loss; meanwhile, implant placement outside of the lesion has shown favourable medium-term results. Data are limited on the long-term efficacy of implants and removable prostheses in managing edentulous sites in patients with florid cemento-osseous dysplasia.
比较用于治疗伴有广泛骨硬化性骨纤维异常增殖症的无牙患者的种植体和可摘义齿的中远期疗效。
本研究检索了 2022 年 12 月至 2023 年 3 月期间的 PubMed、Web of Science 和 Google Scholar 数据库。两名独立的审查员使用人群、干预、比较、结局和时间问卷完成了搜索。根据严格的纳入和排除标准选择文章。采用 Preferred Reporting Items for Systematic Reviews and Meta-Analyses 工作流程来表示纳入和排除文章的数量。使用 Joanna Briggs 研究所Critical Appraisal Checklist 分析偏倚风险。从纳入的文章中提取以下信息：人口统计学、并存的医学状况、广泛骨硬化性骨纤维异常增殖症的特征（临床、影像学和组织学）、在无牙部位进行的干预（种植体或可摘义齿的放置）、干预后的结局（并发症、成功率、骨丢失、种植体丢失和复发）以及随访时间。
最终有 6 篇文章纳入了分析，报道的用于修复无牙部位的装置为种植体和可摘义齿。在患有广泛骨硬化性骨纤维异常增殖症的患者中放置了 11 个种植体，存活率为 91%。3 个可摘义齿全部交付使用，均出现症状并需要手术干预。
患有广泛骨硬化性骨纤维异常增殖症的患者使用可摘义齿可能会出现并发症。在广泛骨硬化性骨纤维异常增殖症病变内放置种植体是不可预测的，可能导致放射性透光区和种植体丢失；而在病变外放置种植体则显示出良好的中期结果。关于种植体和可摘义齿在治疗广泛骨硬化性骨纤维异常增殖症患者无牙部位的长期疗效的数据有限。
